CALIBRIUM

Calibrium is an emerging privately-held biopharmaceutical company focused on developing a portfolio of novel drug candidates for the treatment of diabetes and related metabolic diseases. Calibrium was co-founded by Fritz French, Calibrium’s Chief Executive Officer, and Richard DiMarchi, PhD, Calibirum’s Chief Scientific Officer.

#People #Financial #Website #More

CALIBRIUM

Industry:

Biotechnology Health Care

Founded:

2012-01-01

Address:

Carmel, Indiana, United States

Country:

United States

Website Url:

http://www.calibrium.com

Total Employee:

251+

Status:

Closed

Contact:

Total Funding:

3.16 M USD

Technology used in webpage:

SPF IPv6

Current Employees Featured

not_available_image

Bernd Kammerlander
Bernd Kammerlander CEO @ Calibrium
CEO
2016-02-01

felix-meyer_image

Felix Meyer
Felix Meyer COO @ Calibrium
COO
2017-02-01

not_available_image

Richard DiMarchi
Richard DiMarchi Co-Founder @ Calibrium
Co-Founder

not_available_image

Tom Eriksson
Tom Eriksson Chief Investment Officer @ Calibrium
Chief Investment Officer
2017-02-01

Founder

fritz-french_image

Fritz French

not_available_image

Richard DiMarchi

Investors List

biocrossroads_image

BioCrossroads

BioCrossroads investment in Convertible Note - Calibrium

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Convertible Note - Calibrium

5am-ventures_image

5AM Ventures

5AM Ventures investment in Convertible Note - Calibrium

Official Site Inspections

http://www.calibrium.com

Host Informations
Whois Informations

Loading ...

More informations about "Calibrium" on Search Engine